Global Acute Myeloid Leukemia Market Analysis, 2020

By Test Type (Blood, Bone Marrow, Imaging (X-rays, CT Scan, Magnetic resonance imaging (MRI) scan, Ultrasound), Lumbar puncture, Others (genetic test)), By Medication (Chemotherapy (Cytarabine, Anthracycline, Cladribine, Etoposide, Others), Stem Cell Transplantation, Targeted Therapies (FLT3 inhibitors, IDH inhibitors, Gemtuzumab ozogamicin, BCL-2 inhibitor, Hedgehog pathway inhibitor), Radiation Therapy, Others), By Route of Administration (Intravenous, Oral, Others), By End-User (Hospitals & Specialty Centers, Laboratories, Others), By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Country (US, Canada, Mexico, Brazil, UK, Germany, France, Italy, China, Japan, South Korea, India, GCC (UAE, Saudi Arabia), South Africa)

  • Healthcare
  • Jul 2020
  • 212
  • HC22030